Shares of Gujarat Kidney and Super Speciality Ltd made a steady debut on the stock exchanges, listing at a 6 per cent premium over the IPO price. The stock opened at around ₹120–121, compared to the issue price of ₹114, indicating healthy investor appetite.
The IPO received strong overall subscription, led by retail investors, reflecting confidence in the company’s healthcare-focused business model. Funds raised through the public issue will be used for expansion, hospital acquisitions, and purchase of medical equipment. The positive listing highlights continued interest in healthcare stocks despite mixed market conditions.